Edwards Lifesciences (EW) Current Assets (2009 - 2026)

Edwards Lifesciences' Current Assets history runs 18 years deep, the most recent figure standing at $6.2 billion for Q1 2026.

• In Q1 2026, Current Assets changed 0.26% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (changed 0.26% YoY), while the FY2025 annual figure was $6.7 billion, up 7.22% from the prior year.
• Current Assets was $6.2 billion for Q1 2026 at Edwards Lifesciences, down from $6.7 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $6.7 billion in Q4 2025 to a low of $3.1 billion in Q4 2022.
• Historically, Current Assets has averaged $4.8 billion across 5 years, with a median of $4.2 billion in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Assets soared 65.4% in 2024, then retreated 5.48% in 2025.
• A 5-year view of Current Assets shows it stood at $3.1 billion in 2022, then jumped by 30.36% to $4.0 billion in 2023, then jumped by 55.74% to $6.3 billion in 2024, then climbed by 7.22% to $6.7 billion in 2025, then dropped by 7.57% to $6.2 billion in 2026.
• The last three Current Assets figures came in at $6.2 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.